BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26563255)

  • 1. Prevention of infection-related cancers in the WHO Western Pacific Region.
    Shin HR; Shin A; Woo H; Fox K; Walsh N; Lo YR; Wiesen E; Varghese C
    Jpn J Clin Oncol; 2016 Jan; 46(1):13-22. PubMed ID: 26563255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The global health burden of infection-associated cancers in the year 2002.
    Parkin DM
    Int J Cancer; 2006 Jun; 118(12):3030-44. PubMed ID: 16404738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.
    Kim YT; Serrano B; Lee JK; Lee H; Lee SW; Freeman C; Oh JK; Alemany L; Bosch FX; Bruni L
    Papillomavirus Res; 2019 Jun; 7():26-42. PubMed ID: 30599280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
    Shi JF; Qiao YL; Smith JS; Dondog B; Bao YP; Dai M; Clifford GM; Franceschi S
    Vaccine; 2008 Aug; 26 Suppl 12():M53-9. PubMed ID: 18945414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of Cervical Cancer, Human Papilloma Virus (HPV) and HPV Vaccination Among Women in Northeast China.
    Ning YE; Liu Y; Xu XY; Zhang XY; Wang N; Zheng LQ
    J Cancer Educ; 2020 Dec; 35(6):1197-1205. PubMed ID: 31338812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimates of the incidence of infection-related cancers in Italy and Italian regions in 2018.
    DE Flora S; LA Maestra S; Crocetti E; Mangone L; Bianconi F; Stracci F; Buzzoni C
    J Prev Med Hyg; 2019 Dec; 60(4):E311-E326. PubMed ID: 31967088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
    Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
    Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.
    Sankaranarayanan R; Anorlu R; Sangwa-Lugoma G; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F47-52. PubMed ID: 24331747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Vaccine and Cervical Cancer Screen project 2 (VACCS 2): Linking cervical cancer screening to a two-dose HPV vaccination schedule in the South-West District of Tshwane, Gauteng, South Africa.
    Snyman LC; Dreyer G; Visser C; Botha MH; van der Merwe FH
    S Afr Med J; 2015 Mar; 105(3):191-4. PubMed ID: 26294825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papilloma virus vaccine for low and middle income countries: A step too soon?
    Jindal HA; Kaur A; Murugan S
    Hum Vaccin Immunother; 2017 Nov; 13(11):2723-2725. PubMed ID: 28846491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, Attitudes and Practices of Sudanese Women Regarding the Pap Smear Test and Cervical Cancer.
    Almobarak AO; Elbadawi AA; Elmadhoun WM; Elhoweris MH; Ahmed MH
    Asian Pac J Cancer Prev; 2016; 17(2):625-30. PubMed ID: 26925654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive control of human papillomavirus infections and related diseases.
    Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
    Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.
    Malo TL; Perkins RB; Lee JH; Vadaparampil ST
    Sex Transm Dis; 2016 Jul; 43(7):438-44. PubMed ID: 27322046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of the Carolina Framework for Cervical Cancer Prevention.
    Moss JL; McCarthy SH; Gilkey MB; Brewer NT
    Gynecol Oncol; 2014 Mar; 132 Suppl 1(0 1):S33-40. PubMed ID: 24333357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases.
    Bosch FX; Tsu V; Vorsters A; Van Damme P; Kane MA
    Vaccine; 2012 Nov; 30 Suppl 5():F1-11. PubMed ID: 23199951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trials and projects on cervical cancer and human papillomavirus prevention in sub-Saharan Africa.
    Adefuye PO; Broutet NJ; de Sanjosé S; Denny LA
    Vaccine; 2013 Dec; 31 Suppl 5():F53-9. PubMed ID: 24331748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.